192 related articles for article (PubMed ID: 16142440)
1. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.
Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J
Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440
[TBL] [Abstract][Full Text] [Related]
2. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.
Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z
Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
Zhou Y; Inaba S; Liu J
Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
6. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
[TBL] [Abstract][Full Text] [Related]
9. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
[TBL] [Abstract][Full Text] [Related]
10. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific expression of breast cancer-specific gene gamma-synuclein.
Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of estrogen receptor signaling by gamma synuclein.
Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE
Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
15. SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice.
Shen PH; Fan QX; Li YW; Zhang W; He XK; Wang Z; Zhang YH
Chin Med J (Engl); 2011 May; 124(10):1524-8. PubMed ID: 21740810
[TBL] [Abstract][Full Text] [Related]
16. Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugs.
Miao S; Wu K; Zhang B; Weng Z; Zhu M; Lu Y; Krishna R; Shi YE
Mol Cancer Ther; 2014 Mar; 13(3):699-713. PubMed ID: 24431077
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of gamma-synuclein contributes to cancer cell survival under endoplasmic reticulum stress.
Hua H; Xu L; Wang J; Jing J; Luo T; Jiang Y
J Pathol; 2009 Mar; 217(4):507-15. PubMed ID: 19009586
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.
Yamamoto Y; Matsuyama H; Chochi Y; Okuda M; Kawauchi S; Inoue R; Furuya T; Oga A; Naito K; Sasaki K
Cancer Genet Cytogenet; 2007 Apr; 174(1):42-7. PubMed ID: 17350465
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.
Lo YL; Yu JC; Chen ST; Hsu GC; Mau YC; Yang SL; Wu PE; Shen CY
Carcinogenesis; 2007 May; 28(5):1079-86. PubMed ID: 17210994
[TBL] [Abstract][Full Text] [Related]
20. Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis.
Jiang Y; Liu YE; Goldberg ID; Shi YE
Cancer Res; 2004 Jul; 64(13):4539-46. PubMed ID: 15231664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]